Is the PBM Now Your Doctor?
Charles Bennett, MD, PhD, MPP, Smart State and Frank P and Jose M Fletcher Chair, Medication Safety and Efficacy, Smart State Center of Economic Excellence, University of South Carolina and […]
Entries by melindaroberts
Preventing Breast Cancer: Research Worth Watching
Susan Love, MD, MBA Chief Visionary Officer, Dr. Susan Love Research Foundation, Encino, CA Q: The goal of the Dr Susan Love Research Foundation is “…..to find the cause of […]
2017 USPSTF on PSA: A Bad Idea
Richard J. Ablin, Ph.D., D.Sc. (hon), Dr. h.c. Professor, Department of Pathology, University of Arizona College of Medicine, The Arizona Cancer Center and BIO5 Institute, Tucson, AZ 85724. Ronald Piana, Freelance […]
Big 2017 Change on PSA by USPSTF
Marc B Garnick, MD, Editor in Chief, HMS Annual Report on Prostate Diseases; Gorman Professor of Medicine, Harvard Medical School and Beth Israel Deaconess Medical Center, Boston, MA . E. David Crawford, […]
Forget Moonshots: Biomedicine Needs an Air Traffic Control System
Jeff Shrager, PhD, Director of Research, Cancer Commons; Adjunct Professor, Symbolic Systems Program, Stanford University Q: There never seem to be enough patients matched to cancer clinical trials to quickly test […]
Proposed FDA “Conditional Approval”- More Details
Al Musella, DPM, President, Musella Foundation For Brain Tumor Research & Information, Inc., Hewlett, NY. Marty Tenenbaum, PhD, Founder and Chair, Cancer Commons, Los Altos, CA. Q: Your April 5, 2017 blog […]
Next Steps for Improving Clinical Evidence and Consistency of Payment for Precision Oncology
Kathryn A. Phillips, PhD, Professor of Health Economics and Health Services Research; Founding Director UCSF Center for Translational and Policy Research on Personalized Medicine; Dept. of Clinical Pharmacy; Institute for Health […]
Conditional Approval: Right Solution for the Wrong Problem
Shannon Brownlee, MS, Senior Vice President of the Lown Institute, a think tank in Boston. She is also co-founder of the Right Care Alliance, a social movement for transforming health care. […]
In Memorium: Richard E. Horowitz, M.D.
by Dr. George Lundberg Searching for Truth in Cancer Clinical Trials Richard E. Horowitz, MD, Clinical Professor of Pathology, Keck School of Medicine at USC; Emeritus Professor of Pathology, UCLA School […]
Fibrolamellar Hepatocellular Carcinoma: Still Rare but Deadly
John R. Craig, MD PhD, Retired pathologist and formerly Medical Director, St. Jude Cancer Center, Fullerton, CA; Member, Board of Directors, FibroFoundation Q: You were the lead author in a […]